IO Biotech (IOBT) Institutional Ownership → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free IOBT Stock Alerts $1.58 +0.08 (+5.33%) (As of 05/9/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for IO Biotech (NASDAQ:IOBT)CurrentInstitutional OwnershipPercentage54.76%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$13.43MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$1.00M Get IOBT Insider Trade Alerts Want to know when executives and insiders are buying or selling IO Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IOBT Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here IO Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2024PFM Health Sciences LP2,341,107$4.40M0.3%+73.0%3.554% 2/13/2024Stonepine Capital Management LLC1,666,037$3.13M1.4%-15.7%2.529% 2/13/2024Armistice Capital LLC1,924,000$3.62M0.0%-10.4%2.920% 11/15/2023Armistice Capital LLC2,148,000$3.03M0.0%N/A3.260% 11/14/2023Stonepine Capital Management LLC1,975,308$2.79M0.9%N/A2.998% 11/14/2023Pivotal bioVenture Partners Investment Advisor LLC864,197$1.22M0.5%N/A1.312% 11/8/2023 Vivo Capital LLC6,173,439$8.71M1.1%+104.7%9.371% 7/25/2023 Summit Trail Advisors LLC43,744$86K0.0%N/A0.152% 2/14/2023RA Capital Management L.P.1,127,260$2.59M0.1%-39.3%3.911% 11/14/2022Psagot Value Holdings Ltd. Israel40,846$111K0.0%N/A0.142% 11/2/2022 Victory Capital Management Inc.43,741$119K0.0%N/A0.152% 2/15/2022Samsara BioCapital LLC1,120,437$7.17M1.4%N/A3.888% 2/15/2022Capital World Investors1,235,000$8.11M0.0%N/A4.286% 2/14/2022Soleus Capital Management L.P.672,734$4.31M0.4%N/A2.335% 2/14/2022Novo Holdings A S3,277,932$20.98M1.0%N/A11.376% (Data available from 1/1/2016 forward) IOBT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IOBT shares? During the previous two years, 9 institutional investors and hedge funds held shares of IO Biotech. The most heavily invested institutionals were Vivo Capital LLC ($8.71M), PFM Health Sciences LP ($4.40M), Armistice Capital LLC ($3.62M), Stonepine Capital Management LLC ($3.13M), RA Capital Management L.P. ($2.59M), Pivotal bioVenture Partners Investment Advisor LLC ($1.22M), and Victory Capital Management Inc. ($119K).Learn more on IOBT's institutional investors. What percentage of IO Biotech stock is owned by institutional investors? 54.76% of IO Biotech stock is owned by institutional investors. Learn more on IOBT's institutional investor holdings. Which institutional investors have been buying IO Biotech stock? The following institutional investors have purchased IO Biotech stock in the last 24 months: Vivo Capital LLC ($3.16M), Armistice Capital LLC ($2.15M), Stonepine Capital Management LLC ($1.98M), PFM Health Sciences LP ($987.65K), Pivotal bioVenture Partners Investment Advisor LLC ($864.20K), Summit Trail Advisors LLC ($43.74K), and Victory Capital Management Inc. ($43.74K). How much institutional buying is happening at IO Biotech? Institutional investors have bought a total of 9,261,384 shares in the last 24 months. This purchase volume represents approximately $13.66M in transactions. Which IO Biotech major shareholders have been selling company stock? The following institutional investors have sold IO Biotech stock in the last 24 months: RA Capital Management L.P. ($730.50K), Stonepine Capital Management LLC ($309.27K), and Armistice Capital LLC ($224K). How much institutional selling is happening at IO Biotech? Institutional investors have sold a total of 1,263,766 shares in the last 24 months. This volume of shares sold represents approximately $2.68M in transactions. Related Companies: Anixa Biosciences Institutional Ownership DiaMedica Therapeutics Institutional Ownership Clearside Biomedical Institutional Ownership Oramed Pharmaceuticals Institutional Ownership Emergent BioSolutions Institutional Ownership BioXcel Therapeutics Institutional Ownership Allakos Institutional Ownership Cellectar Biosciences Institutional Ownership Adagene Institutional Ownership PMV Pharmaceuticals Institutional Ownership This page (NASDAQ:IOBT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 MediaUrgent Nvidia WarningAltimetryThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
